Evidence map›Paper›PMID 22920589›Full record

ArticleJournal of bioscience and bioengineering2013

Efficient bioconversion of quercetin into a novel glycoside by Streptomyces rimosus subsp. rimosus ATCC 10970.

Bingji Ma, Jia Zeng, Lei Shao, Jixun Zhan

Open access · greenAbstract read
In one paragraph

Article in Journal of bioscience and bioengineering, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Bingji MaDepartment of Biological Engineering, Utah State University, Logan, UT 84322-4105, USA.
Jia Zeng
Lei Shao
Jixun Zhan
Utah State University · US

Funding

Vascular stabilization as a broad theraprutic platform for biodefenseU54AI065357 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI SCHWEIZER, HERBERT P. · 2005 to 2013
$77.5M
NIAID NIH HHS AI065357NIAID NIH HHS U54 AI065357
6 · The paper itself

Abstract

Incubation of quercetin with Streptomyces rimosus subsp. rimosus ATCC 10970 yielded an unusual glycosylated derivative. The structure of the product was determined to be quercetin-7-O-β-4″-deoxy-hex-4″-enopyranosiduronic acid based on the spectral data. Quercetin was completely converted into the glycoside in 72 h.

Indexed as

BiotransformationGlycosidesGlycosylationQuercetinStreptomyces rimosusGlycosidesQuercetinquercetin-7-O-beta-4''-deoxy-hex-4''-enopyranosiduronic acid

Identifiers

PMID22920589
PMCPMC3504127
OpenAlexW2121271194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.